ethyl 3,3-bis(4-bromophenyl)acrylate | 494865-05-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl 3,3-bis(4-bromophenyl)acrylate
• 英文别名: 3,3-Bis-(4-bromophenyl)-acrylic acid ethyl ester；ethyl 3,3-bis(4-bromophenyl)prop-2-enoate
• CAS: 494865-05-3
• 化学式: C₁₇H₁₄Br₂O₂
• 分子量: 410.105
• InChiKey: OAWNOOBKZRTBPV-UHFFFAOYSA-N

物化性质

• 沸点：
  463.4±35.0 °C(Predicted)
• 密度：
  1.543±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  ethyl 3,3-bis(4-bromophenyl)acrylate 在 sodium hydroxide 、 三丁基膦 、 二异丁基氢化铝 、 1,1'-azodicarbonyl-dipiperidine 作用下， 以 四氢呋喃 、 乙醇 、 甲苯 为溶剂， 反应 64.0h， 生成 3-{4-[3,3-Bis-(4-bromo-phenyl)-allyloxy]-phenyl}-propionic acid
  参考文献：
  名称：

  Identification and Synthesis of a Novel Selective Partial PPARδ Agonist with Full Efficacy on Lipid Metabolism In Vitro and In Vivo

  摘要：

  The aim was to identify a novel selective PPAR delta agonist with full efficacy on free fatty acid (FFA) oxidation in vitro and plasma lipid correction in vivo. Using the triple PPAR alpha,gamma,delta agonist 1 as the structural starting point, we wanted to investigate the possibility of obtaining selective PPAR delta agonists by modifying only the acidic part of 1, while holding the lipophilic half of the molecule constant. The structure-activity relationship was guided by in vitro transactivation data using the human PPAR receptors, FFA oxidation efficacy performed in the rat muscle L6 cell line, and in vivo rat pharmacokinetic properties. Compound 7 ([4-[3,3-bis-(4-bromo-phenyl)-allylthio]-2-chloro-phenoxy]-acetic acid) was identified as a selective, partial agonist with good oral pharmacokinetic properties in rat. Chronic treatment of high fat fed ApoB100/CETP-Tgn mice with 7 corrected the plasma lipid parameters and improved insulin sensitivity. These data suggest that selective PPAR delta agonists have the potential to become a novel treatment of dyslipidemia.

  DOI：

  10.1021/jm061202u
• 作为产物：
  描述：

  4,4'-二溴二苯甲酮 在 锌 、 苯 作用下， 生成 ethyl 3,3-bis(4-bromophenyl)acrylate
  参考文献：
  名称：

  Bergmann; Hoffmann; Meyer, Journal fur praktische Chemie (Leipzig 1954), 1932, vol. <2> 135, p. 245,252

  摘要：

  DOI：

文献信息

• Photoinduced Oxidative Alkoxycarbonylation of Alkenes with Alkyl Formates
  作者：Wan-Ying Tang、Ling Chen、Ming Zheng、Le-Wu Zhan、Jing Hou、Bin-Dong Li

  DOI：10.1021/acs.orglett.1c01096

  日期：2021.5.21

  A photoinduced oxidative alkoxycarbonylation of alkenes initiated by intermolecular addition of alkoxycarbonyl radicals has been demonstrated. Employing alkyl formates as alkoxycarbonyl radical sources, a range of α,β-unsaturated esters were obtained with good regioselectivity and E selectivity under ambient conditions.

  已经证明了通过分子间加成烷氧基羰基引发的烯烃的光诱导氧化烷氧基羰基化。利用烷基甲酸酯作为烷氧羰基自由基源，在环境条件下获得了一系列具有良好区域选择性和E选择性的α，β-不饱和酯。
• Palladium-Catalyzed Intramolecular Amidation of C(sp²)−H Bonds: Synthesis of 4-Aryl-2-quinolinones
  作者：Kiyofumi Inamoto、Tadataka Saito、Kou Hiroya、Takayuki Doi

  DOI：10.1021/jo100557s

  日期：2010.6.4

  A catalytic synthetic approach for the synthesis of 2-quinolinone compounds through a Pd-catalyzed C(sp2)−H functionalization/intramolecular amidation sequence is described. The cyclization process efficiently proceeds in the presence of a catalytic amount of PdCl2 and Cu(OAc)2 under an O2 atmosphere, providing practical access to a range of variously substituted 4-aryl-2-quinolinones.

  描述了一种通过Pd催化的C（sp 2）-H官能化/分子内酰胺化序列合成2-喹啉酮化合物的催化合成方法。在O 2气氛下，在催化量的PdCl 2和Cu（OAc）2的存在下，环化过程有效地进行，从而提供了各种不同取代的4-芳基-2-喹啉酮的实用途径。
• Novel compounds, their preparation and use
  申请人：Jeppesen Lone

  公开号：US20050080115A1

  公开（公告）日：2005-04-14

  Novel compounds of the general formula (I), the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ suptype.

  通用公式（I）的新化合物，这些化合物作为药物组成部分的用途，包含这些化合物的药物组成部分以及使用这些化合物和组成部分进行治疗的方法。这些化合物可能在治疗和/或预防由过氧化物酶体增殖物激活受体（PPAR）介导的疾病中有用，特别是PPARδ亚型。
• Palladium-catalyzed double arylations of terminal olefins in acetic acid
  作者：Daichao Xu、Chunxin Lu、Wanzhi Chen

  DOI：10.1016/j.tet.2011.12.017

  日期：2012.2

  A palladium-catalyzed Heck diarylation of terminal olefins under ligand-free conditions in acetic acid is described. This procedure allows double arylation of terminal olefins affording trisubstituted olefins in good to excellent yields. The methodology is applicable to the coupling of both electron-deficient and electron-rich aryl iodides leading to symmetrical and unsymmetrical β,β-diarylated alkenes

  描述了在无配体条件下在乙酸中钯催化的末端烯烃的Heck二芳基化。该方法允许末端烯烃进行双芳基化，从而以良好至优异的产率提供三取代的烯烃。该方法适用于缺电子和富电子的芳基碘化物的偶合，从而导致对称和不对称的β，β-二芳基化烯烃。
• [EN] NOVEL COMPOUNDS USEFUL IN TREATING PPAR MEDIATED DISEASES<br/>[FR] NOUVEAUX COMPOSES TRAITANT LES MALADIES MEDIEES PAR LE PPAR
  申请人：NOVO NORDISK AS

  公开号：WO2004037775A1

  公开（公告）日：2004-05-06

  Novel compounds of the general formula (I), the use of these compounds as pharma-ceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ suptype.

  通用公式（I）的新化合物，这些化合物作为药物组合物的用途，包含这些化合物的药物组合物以及利用这些化合物和组合物进行治疗的方法。这些化合物可能在治疗和/或预防由过氧化物酶体增殖物激活受体（PPAR）介导的疾病中有用，特别是PPARδ亚型。